COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets is a research paper published in Nature (2021). On theSindex it has a DataRank of 10.7. It has been cited 879 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.0
From this paper's citation signal
Citation Network Contribution
9.7
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
National Institutes of Health
Grant: 1DP2CA247831-01
Deciphering the Achilles Heel of Cancer Immunotherapy
National Institutes of Health
Grant: 7K08CA222663-04
Dissecting mechanisms of immunotherapy resistance in melanoma patients
National Institutes of Health
Grant: 5R37MH107649-07
Statistical methods to localize disease heritability and identify biological mechanisms
National Institutes of Health
Grant: 5U54CA225088-05
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
National Institutes of Health
Grant: 3P30CA013696-21S1
CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 7U01AA026933-03
Biomarkers of Disease in Alcoholic Hepatitis
National Institutes of Health
Grant: 2R01MH101244-11
Functional and population genetic architectures of complex disease
National Institutes of Health
Grant: 5U01HG009379-03
Functionally specialized components of disease heritability in ENCODE data
National Institutes of Health
Grant: 5R37CA258829-04
Mechanisms of liver metastasis and associated resistance to immunotherapy
NIMH NIH HHS
Grant: R37 MH107649
NCI NIH HHS
Grant: K08 CA222663
NIGMS NIH HHS
Grant: T32 GM007753
NIDDK NIH HHS
Grant: P30 DK046200
NIAAA NIH HHS
Grant: R01 AA017729
NCI NIH HHS
Grant: P30 CA013696
NHLBI NIH HHS
Grant: UH3 HL141797
NIMH NIH HHS
Grant: R01 MH107649
NIMH NIH HHS
Grant: R01 MH101244
NIAAA NIH HHS
Grant: R01 AA020744
NCI NIH HHS
Grant: R37 CA258829
NCI NIH HHS
Grant: U54 CA225088
NIAAA NIH HHS
Grant: U01 AA026933
NIDDK NIH HHS
Grant: P30 DK043351
NHGRI NIH HHS
Grant: U01 HG009379
NCI NIH HHS
Grant: DP2 CA247831
Wellcome Trust
Howard Hughes Medical Institute
FWCI
56.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
Additional file 1 of SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
Additional file 1 of Coronavirus disease 2019-related myocarditis genes contribute to ECMO prognosis
Additional file 1 of Coronavirus disease 2019-related myocarditis genes contribute to ECMO prognosis
Additional file 1 of Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections
Additional file 1 of Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections
Additional file 14 of Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections
Additional file 14 of Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections
Additional file 7 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 4 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 2 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 1 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 7 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 9 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 4 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 6 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 8 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 1 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 2 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
Additional file 8 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients